Want to see MAIA full AI Analyst Report?
MAIA Biotechnology, Inc. (MAIA) Ownership - Who Owns MAIA Biotechnology, Inc.?
MAIA Biotechnology, Inc. (MAIA) Ownership Overview
- 8.83% Insiders
- 4.77% Mutual Funds
- 0.13% Other Institutional Investors
- 4.18% ETFs
- 82.09% Public Companies and Individual Investors
The ownership structure of MAIA Biotechnology, Inc. (MAIA) stock is a mix of institutional, retail, and individual investors. Approximately 9.08% of the company’s stock is owned by Institutional Investors, 8.83% is owned by Insiders, and 82.09% is owned by Public Companies and Individual Investors.
The ownership structure of MAIA Biotechnology, Inc. (MAIA) stock is a mix of institutional, retail, and individual investors. Approximately 4.90% of the company’s stock is owned by Institutional Investors, 8.83% is owned by Insiders, and 4.18% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| Sep 14, 2026 | Vlad Vitoc | $100,010 | |
| Sep 13, 2026 | Ramiro Guerrero | $49,249 | |
| Aug 31, 2026 | Ramiro Guerrero | $184,103 | |
| Aug 25, 2026 | Ramiro Guerrero | $2,386 |
Recent Hedge Fund Trading Activity
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard | 2,344,976 | Institution | 3.80% | 2,579,474 |
| Vanguard Index Funds | 2,344,976 | Institution | 3.80% | 2,579,474 |
| Stan Smith | 1,532,918 | Insider | 2.48% | 1,686,210 |
| Vlad Vitoc | 1,259,221 | Insider | 2.04% | 1,385,143 |
| Louie Ngar Yee | 1,248,888 | Insider | 2.02% | 1,373,777 |
| Ramiro Guerrero | 773,296 | Insider | 1.25% | 850,626 |
| Fidelity Concord Street Trust | 458,302 | Institution | 0.74% | 504,132 |
| Cristian Luput | 437,628 | Insider | 0.71% | 481,391 |
| Ishares | 162,384 | Institution | 0.26% | 178,622 |
| Steven M Chaouki | 151,873 | Insider | 0.25% | 167,060 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Index Funds | 2,344,976 | Institution | 3.80% | 2,579,474 |
| Fidelity Concord Street Trust | 458,302 | Institution | 0.74% | 504,132 |
| Bridgeway Funds, Inc. | 76,000 | Institution | 0.12% | 83,600 |
| Vanguard Institutional Index Funds | 39,706 | Institution | 0.06% | 43,677 |
| Vanguard Valley Forge Funds | 28,588 | Institution | 0.05% | 31,447 |
Top ETF Holders
FAQ
Who Owns MAIA Biotechnology, Inc. (MAIA)?
According to the latest TipRanks data, approximately 0.13% of the company's stock is held by institutional investors, 8.83% is held by insiders, and 82.09% is held by retail investors.
What percentage of MAIA Biotechnology, Inc. (MAIA) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.13% of MAIA Biotechnology, Inc. (MAIA) stock is held by institutional investors.
What percentage of MAIA Biotechnology, Inc. (MAIA) stock is held by retail investors?
According to the latest TipRanks data, approximately 82.09% of MAIA Biotechnology, Inc. (MAIA) stock is held by retail investors.
Who owns the most shares of MAIA Biotechnology, Inc. (MAIA)?
Vanguard owns the most shares of MAIA Biotechnology, Inc. (MAIA).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.